Evidence map›Paper›PMID 40862438›Full record

ArticleCadernos de saude publica2025

Survival time analysis in women with breast cancer using distributional regression models.

Isabela da Silva Lima, Sóstenes Jerônimo da Silva, Carla Regina Guimarães Brighenti, Luiz Ricardo Nakamura, Tiago Almeida de Oliveira, Milena Edite Casé de Oliveira, Thiago Gentil Ramires

Abstract read
In one paragraph

Article in Cadernos de saude publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Isabela da Silva LimaPrograma de Pós-graduação em Estatística e Experimentação Agropecuária, Universidade Federal de Lavras, Lavras, Brasil.ORCID 0000-0001-9955-4465
Sóstenes Jerônimo da SilvaPrograma de Pós-graduação em Biometria e Estatística Aplicada, Universidade Federal Rural de Pernambuco, Recife, Brasil.ORCID 0000-0002-5981-4266
Carla Regina Guimarães BrighentiDepartamento de Zootecnia, Universidade Federal de São João del-Rei, São João del-Rei, Brasil.ORCID 0000-0002-7822-3744
Luiz Ricardo NakamuraDepartamento de Estatística, Universidade Federal de Lavras, Lavras, Brasil.ORCID 0000-0002-7312-2717
Tiago Almeida de OliveiraDepartamento de Estatística, Universidade Estadual da Paraíba, Campina Grande, Brasil.ORCID 0000-0003-4147-7721
Milena Edite Casé de OliveiraDepartamento de Psicologia, Centro Universitário Tabosa de Almeida, Caruaru, Brasil.ORCID 0000-0003-2266-5890
Thiago Gentil RamiresDepartamento de Matemática, Universidade Tecnológica Federal do Paraná, Curitiba, Brasil.ORCID 0000-0002-1972-7045

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a global public health concern due to its high mortality rates. In Brazil, breast cancer is one of the leading causes of disease and death among women in all regions of the country, with higher mortality rates in less developed regions. Hence, this study analyzes variables associated with survival time in breast cancer patients in Campina Grande, Paraíba State, Brazil. Distributional regression models, also known as generalized additive models for location, scale, and shape (GAMLSS), were used due to their flexibility in explaining complex behaviors of a given response (for example, survival time) based on other variables. Tumor site, age, number of hormone therapy, radiotherapy and chemotherapy sessions, and molecular markers such as estrogen receptor, progesterone receptor, Ki-67 protein, p53, HER2 mutation and molecular subtype were examined. Two different GAMLSS were fitted considering Weibull and log-normal distributions, the former of which is more appropriate per the Akaike information criterion. Using a variable selection procedure specific to GAMLSS, we identified four covariates that directly affect average survival time: number of hormone therapy and chemotherapy sessions, p53 status, and estrogen receptor status. Excepting estrogen receptor status, the other covariates selected to explain average survival time were also used to explicitly explain the variability of these times.

Indexed as

Breast NeoplasmsAdultAgedBrazilFemaleHumansMiddle AgedRegression AnalysisSurvival Analysis

Identifiers

PMID40862438
PMCPMC12404312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.